HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis
HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis have?
HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis has 42 citations in the OpenAlex counts ScholarIQ stores.
When was HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis published?
HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis has 2022 year in the ScholarIQ index.
What is the open-access status of HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis?
HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis has closed oa status in the ScholarIQ index.
What is the DOI of HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis?
The DOI for HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis is on the source record.
What is the PMID of HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis?
The PMID for HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis is on the source record.
What is the OpenAlex record for HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis?
The OpenAlex for HYPORT adjuvant acute toxicity and patient dosimetry quality assurance results – Interim analysis is on the source record.